October 18, 2017 10:59 PM ET

Pharmaceuticals

Company Overview of Taizhou SPH Pharmaceutical Co., Ltd.

Key Executives for Taizhou SPH Pharmaceutical Co., Ltd.

NameBoard RelationshipsTitleAge
Hai Bo Wang 19 RelationshipsChairman of the Board and General Manager57
Jun Li No RelationshipsCo-Founder and Deputy General Manager49
Yong Su 19 RelationshipsExecutive Director53
Da Jun Zhao 19 RelationshipsExecutive Director47

Taizhou SPH Pharmaceutical Co., Ltd. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Hai Bo Wang 19 RelationshipsShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.57
Yong Su 19 RelationshipsShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.53
Da Jun Zhao 19 RelationshipsShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.47
Zhonghui Zhou 93 RelationshipsShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.70
Yiu Kin Lam 80 RelationshipsShanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.62
View All Board Members

Taizhou SPH Pharmaceutical Co., Ltd. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Yiu Kin Lam80 Relationships3 Executives
Compensation Committee Zhonghui Zhou93 Relationships3 Executives
Nominating Committee Hai Bo Wang19 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
380.4K
Bonus
412.6K
Total Short Term Compensation
527.7K
Total Value of Options
8.0M
Compensation as of Fiscal Year
Taizhou SPH Pharmaceutical Co., Ltd. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Ritter Pharmaceuticals, Inc. Appoints Jeffrey Benjamin as Vice President, Finance, Effective October 16, 2017
October 17, 2017 8:18 PM ET
Pernix Therapeutics Holdings, Inc. Announces Executive Changes
October 17, 2017 8:05 PM ET
Bayer Appoints Brenda L. Raphael as Senior Vice President and General Manager of the Therapeutics Business Unit of Consumer Health Commercial Operations North America, Effective October 30, 2017
October 17, 2017 4:01 PM ET
Weifa ASA Announces Board Appointments
October 17, 2017 3:46 PM ET
Alkem Laboratories Limited Announces Executive Changes
October 17, 2017 12:26 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Taizhou SPH Pharmaceutical Co., Ltd., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.